EUS Users Group Meeting Wednesday 26 November 2014
Transcription
EUS Users Group Meeting Wednesday 26 November 2014
EUS Users Group Meeting Wednesday 26th November 2014 08.30 Registration 08.55 Welcome and Introduction Dr Manu Nayar, Consultant Gastroenterologist and HPB Physician, Freeman Hospital, Newcastle 09.00 Oesophagogastric EUS: Present and future Dr Ray McCrudden, Consultant Gastroenterologist, Royal Bournemouth General Hospital Chair: Dr Raymond McCrudden 09.30 Live cases: Controversial OG case Dr Nicholas Carroll, Consultant Radiologist and Endoscopist, Addenbrookes Hospital, Cambridge Mr Shaun Preston, Consultant Oesophagogastric Surgeon, Royal Surrey County Hospital, Guildford 10.10 Eastography and Contrast EUS Professor Adrian Saftiou. Professor of Diagnostic and Therapeutic techniques in Gastroenterology University do Medicine and Pharmacy, Craiova, Romania 10.40 Coffee Chair: Mr Colin McKay 11.00 Live cases: Solid pancreatic lesions Dr Kofi Oppong, Consultant HPB Physician, Freeman Hospital, Newcastle Dr Brinder Mahon, Consultant Radiologist, University of Birmingham NHS Trust 11.40 Recent advances in EUS guided fine needle aspiration Mr Colin McKay, Consultant Pancreatic Surgeon Glasgow Royal Infirmary 12.00 Advances in the diagnosis of pancreatic cysts Dr Kofi Oppong, Consultant HPB Physician, Freeman Hospital, Newcastle Chair: Dr Kofi Oppong 12.20 Live cases: Indeterminate pancreatic cysts Dr Steve Pereira, Reader in Hepatology and Gastroenterology University College, London Dr Ray McCrudden, Consultant Gastroenterologist, Royal Bournemouth General Hospital 13.00 Lunch Chair: Dr Elaine Henry 13.30 Training and education in EUS in the UK Dr Nicholas Carroll, Consultant Radiologist and Endoscopist, Addenbrookes Hospital, Cambridge 13.50 UK EUS research – how do we take it forward? Dr Steve Pereira, Reader in Hepatology and Gastroenterology University College, London 14.00 Drainage of peripancreatic collections Mr Richard Charnley, Consultant Pancreatic Surgeon, Freeman Hospital, Newcastle Chair: Mr Richard Charnley 14.30 Live cases: Pseudocyst drainage Mr Tim Worthington, Consultant HPB Surgeon, Royal Surrey County Hospital NHS Foundation Trust, Guildford 15.30 Endoscopic pancreatic necrosectomy Dr Manu Nayar, Consultant Gastroenterologist Freeman Hospital, Newcastle 15.50 Future of therapeutic EUS Dr Alberto Larghi, Digestive Endoscopy Unit Università Cattolica del Sacro Cuore, Rome, Italy 16.20 Cytology results Dr Louise Daborn, Consultant Cytologist Royal Surrey County Hospital, Guildford 16.45 The future of the UK EUS users group Dr Brinder Mahon, Consultant Radiologist, University of Birmingham NHS Trust 17.00 Close 18.00 UK EUS users group committee meeting 19.30 UK EUS users dinner, Holiday Inn, Guildford 40th Annual Scientific Meeting Pancreatic Society of Great Britain and Ireland Thursday 27th November 9am Registration opens 09.30 Welcome: Mary Phillips, President PSGBI and Cllr. David Elms, Mayor of Guildford Session 1: Pancreatitis and benign disease Chair: Local Chair: Mr. Jeremy French, Dr Steve Pereira Professor Nariman Karanjia, Mr Neville Menezes 09.35 Fluid management in the critically ill pancreatic patient Dr Michael Scott, Consultant in Anaesthesia and Intensive Care Medicine, Guildford 10.00 Debate: Resection for pain management in chronic pancreatitis FOR: Mr Richard Charnley, Consultant Pancreatic Surgeon, Freeman Hospital, Newcastle AGAINST: Professor Ajith Siriwardena, Professor of Hepatobiliary Surgery, University of Manchester & Consultant Hepatobiliary Surgeon, Manchester Royal Infirmary 10.30 11am Diagnosis and management of Sphincter of Oddi dysfunction Dr Kofi Oppong, Consultant HPB Physician, Freeman Hospital Newcastle Coffee Break Session 2: Pancreatitis and benign disease Chair: Local Dr Andrew Hart, Mr Ross Carter Dr Michelle Gallagher, Professor David Russell-Jones Chair: 11.30 Diabetes mellitus secondary to pancreatic diseases (Type 3c diabetes) Dr.Nils Ewald, Associate Professor of Internal Medicine / Endocrinology and Diabetology, Justus-Liebig-University Giessen and General Hospital Luebbecke-Rahden 11.55 Acute pancreatitis international guidelines update Professor Robert Sutton, Professor of Surgery, Royal Liverpool Hospital 12.20 Extreme pancreatitis Mr Euan Dickson, Consultant Pancreatic Surgeon, Glasgow Royal Infirmary 12.45 Lunch, posters and trade stands Session 3: Pancreatic Cancer Chair: Local Chair: Dr Stephen Falk, Dr Sinead Duggan Ms. Angela Riga, Mr Ben Cresswell 13.45 Cancer associated malnutrition, cachexia and sarcopenia in the era of obesity Dr Aoife Ryan, Lecturer in Nutritional Sciences, University College, Cork 14.10 Management of cancer cachexia Professor Kenneth Fearon, Professor of Surgery, Edinburgh Royal Infirmary 14.35 Dietary therapies: Fact or fiction: Tanya Klopper and Lindsey Bottle, Macmillian Oncology Dietitians, Royal Surrey County Hospital, Guildford 15.00 Debate: Should patients with operable disease have neoadjuvant chemotherapy FOR: Professor Kevin Conlon, Professor of Surgery, Trinity College, Dublin AGAINST: Mr Mohammed Abu-Hilal, Consultant Pancreatic Surgeon, Southampton University Hospital 15.30 Coffee Break Session 4: Pancreatic Cancer Chair: Local Chair: Dr. Mark Callaway, Dr Manu Nayer Dr Andrew Hatrick, Dr Fuad Hussain, Mr Tim Worthington 16.00 PET-CT and PET-Panc update. Professor Paula Ghaneh, Professor of Surgery, University of Liverpool 16.25 Coeliac Axis embolisation, Dr Nick Woodward, Consultant Interventional Radiologist, Royal Free Hospital, London 16.50 EUS as a staging tool in pancreatic cancer. Professor Adrian Saftiou. Professor of Diagnostic and Therapeutic techniques in Gastroenterology University do Medicine and Pharmacy, Craiova, Romania 17.30 Guidelines Group Meeting Parallel Session: Clinical Nurse Specialist Symposium 09.40 Welcome to the CNS symposium Sophie Noble, HPB CNS, Leicester 09.45 'How to survive a whipple - potential pitfalls and avoiding disasters..... Graham Pinn Lead Upper GI Clinical Nurse Specialist, Guildford 10.15 The inside story – running a support service Di Dobson, Pancreatic Cancer Nurse Specialist, PCUK 10.45 Starting up a patient support group Sophie Noble, HPB CNS, Leicester 11am Coffee Break 11.30 Regional Pancreatitis Network Gill Henderson, Pancreatitis Nurse Specialist, Newcastle 12.00 Pancreatic malignancy and nutrition – a study of clinical practice Lynne McCallum, HPB & NET Clinical Nurse Specialist, Manchester 12.15 What next for the nurses at Pan Soc?’ – open discussion from the floor on nurse presentation at the Pancreas Society – Sophie Noble, HPB CNS, Leicester Pancreatology in Primary Care Thursday 27th November 2014 Parallel Session 3: Pancreatology for Primary Care 13.30 Chairs: GP Registration and Trade Stands Professor Nariman Karanjia, Mrs Alison Stunt, Mrs Penny Lown, 13.45 Diagnosing pancreatic cancer, Dr Ishani Patel, Transforming Cancer Services Team, London 14.10 Surgical management of pancreatic cancer and chronic pancreatitis, Ms Nadeen Low, Consultant Surgeon, St Georges Hospital, London 14.35 Post operative complications in primary care, Mr Marcos Kostalas Surgical Registrar & Mr Neville Menezes, Consultant HPB Surgeon, Guildford 15.00 Long term management of pancreatic exocrine insufficiency. Mary Phillips, HPB Specialist Dietitian, Guildford 15.30 Coffee Break Chairs: Ms. Angela Riga, Mrs Alison Stunt, Mrs Penny Lown 16.00 Psychology of chronic pain / disease Ms. Katherine May, Consultant Clinical Psychologist, Guildford 16.25 Managing Diabetes in the pancreatic patient Dr Roselle Herring, Consultant Physician, Diabetes and Endocrinology, Guildford 16.50 Supportive care for patients with pancreatic cancer Dr Andrew Davies, Clinical Director Supportive & Palliative Care, Guildford 17.15 Questions and Close 40th Annual Scientific Meeting Pancreatic Society of Great Britain and Ireland Friday 28th November Session 5: Oral Presentations (8 minutes plus 2 minutes for questions) Chair: Local Chair: Dr Bill Greenhalf, Professor Colin Johnson, Ms. Nadeen Low 09.00 The role of the reverse Warburg effect and monocarboxylate transporters in the tumour microenvironment of pancreatic cancer. John Moir1,2, Jelena Mann2, Steven White1 1 HPB Unit, Freeman Hospital, Newcastle Upon Tyne. Fibrosis Lab, ICM, Newcastle University 2 09.10 A novel combined therapeutic intervention for pancreatic cancer using oncolytic viral therapy and photodynamic therapy. Yazan S. Khaled1,2,3, Kathleen E. Wright1, Alan A. Melcher2, David G. Jayne1, Andrew M. Smith3 1 Section of Translational Anaesthesia and Surgery, St James’s University Hospital, Leeds, UK. 2Targeted and Biological Therapies, University of Leeds, Leeds, UK. 3Department of Pancreatobiliary Surgery, St James’s University Hospital, Leeds, UK 09.20 Predictive value of drain amylase concentration for development of pancreatic fistula after pancreaticoduodenectomy. Piotr Zelga 1, Jason M Ali1, Rebecca Brais2 , Raaj K Praseedom1, Emmanuel L Huguet1, Neville V Jamieson1, Simon JF Harper1, Siong S Liau1, Asif Jah1 1 HPB & Transplant Surgery Unit, Cambridge University Hospitals NHS Department of Histopathology, Cambridge University Hospitals NHS Trust, Cambridge, UK 2 09.30 A single P53 mutation may predict survival in intraductal papillary mucinous neoplasms of the pancreas. Nicholson JA1, Howes N2, Harrison S1, Büchler M3, Yan Li1, Lane B1, Garner E1, Bullock K1, Sutton R1,2, Campbell F2, Neoptolemos JP1,2, Greenhalf W 1. 1 NIHR Pancreas Biomedical Research Unit, Liverpool. 2Royal Liverpool University Hospital. 3Abteilung für Allgemeine, Viszerale und Unfallchirurgie Universität Heidelberg Deutschland 09.40 The relationships of ezrin, beta-catenin, ecadherin,K167 and vascular endothelial growth factor immunoexpression in pancreatic carcinoma R.Dina, S. Ndagiri, Imperial College London 09.50 Insertion of fully-covered metal biliary stents is associated with a higher incidence of post-ERCP pancreatitis than plastic stents Iain JD McCallum, Jeremy Maarschalk, John Scott, Kofi Oppong, Manu Nayar, Richard M Charnley, HPB surgical unit, Freeman Hospital, Newcastle upon Tyne. 10.00 Toll-like receptor-mediated IL-6 production is an early predictor of post-operative systemic inflammatory response syndrome (SIRS) in patients undergoing major hepato-pancreaticobiliary (HPB) surgery. Rajiv Lahiri 1,2, Yannick Derwa1, Zohra Bashir1, Edward Giles1, Alastair O’Brien3, Andrew Stagg1, Satyajit Bhattacharya2, Graham R. Foster1,2 , William Alazawi1,2 1 Department of Hepatology, Centre for Digestive Diseases, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London. 2Barts Health HPB Centre, Royal London Hospital, 3University College London 10.10 Outcomes following resection of metastatic disease to the pancreas M. Pitchairmuthu, M.S. Khan, C. Coldham, R. Marudanayagam, R. Sutcliffe, D. Mirza, P. Muiesan, J. Isaac, K. Roberts. Birmingham Liver Unit, Queen Elizabeth Hospital, Birmingham 10.20 Coffee Session 6: Pancreatic Surgery Chair Local Chair Mr Andrew Smith, Mr Keith Roberts, Professor John Neoptolemos Mr Tim Worthington 10.40 Laparoscopic Whipples: Mr Zac Rahman, Consultant Pancreatico-biliary and Advanced Laparoscopic Upper GI Surgeon, Royal Free London NHS Foundation Trust 11.05 Achieving excellence in pancreatic surgery. Professor Markus Bűchler, Professor of Surgery, University of Heidelberg, Germany Session 7: Pancreatic Cancer Chair: Local Chair: Professor Robert Sutton Dr Christopher Tibbs, Dr Sebastian Cummins 11.30 Pain Management in pancreatic cancer, Dr Adrian Tookman, Consultant in Palliative Medicine, Marie Curie 11.55 Genetics and Chemotherapy, Dr Bill Greenhalf, Reader in Molecular Biology, University of Liverpool 12.30 Lunch Session 8: Posters session (3 minutes + 2 for questions) Chair: Local Chair: Mr Colin McKay, Dr Alistair Makin Mr Rajesh Kumar 13.30 Presentation A 13.35 Presentation B 13.40 Presentation C 13.45 Presentation D 13.50 Presentation E 13.55 Presentation F 14.00 Presentation G 14.05 Presentation H Session 9: Chemotherapy Trials Update Chair: Local Chair: Dr Kapli Kapur Dr Tony Dhillon, Dr Marianne Illsley 14.20 SCALOP II Radiotherapy + folfirinox + Gem-abraxane vs. chemo alone Incorporates Nelfinavir (HIV) as radiosensitiser plus dose escalation Dr Sebastian Cummins, Consultant Oncologist, Royal Surrey County Hospital, Guildford 14.45 Update on clinical trials for pancreatic neuroendocrine Tumours Dr Richard Hubner, Consultant Oncologist and Honorary Senior Lecturer, The Christie Hospital and University of Manchester 15.10 Update on chemotherapy clinical trials Dr Bristi Basu, Consultant Oncologist, Addenbrookes Hospital, Cambridge 15.35 Coffee 16.00 AGM and presentation of prizes. Handover of Presidency from Mary Phillips to Andrew Hart 16.30 Close Nutrition Interest Group (NIGPS) Symposium Friday 28th November 2014 Chair: 09.00 Practical session on tube feeding tbc 09.30 An update on the use of glutamine: evidence on its use in pancreatic disease. Mr Peter Turner, Liverpool 10.00 Nutritional management of type 3c diabetes Dr Sinead Duggan, Trinity College Dublin 10.30 Coffee 11.00 The impact of nutrition on penetrance in patients with inherited disease of the exocrine pancreas Dr Bill Greenhalf, Reader in Molecular Biology, University of Liverpool 11.30 The evaluation of body composition in pancreatic disease Mr Donal O’Connor, Senior Lecturer, Trinity College Dublin 12.30 Lunch Use of CT scanning to detect and monitor sarcopenia 13.30 With specific software Mr Donal O’Connor, Senior Lecturer, Trinity College, Dublin 14.00 Assessment of sarcopenia using CT imaging Ms. Samantha Cushen, Research Dietitian, University College, Cork 14.35 Presentation skills for Dietitians Ms. Anne Holdoway, Specialist Dietitian and Chair of the Parenteral and Enteral Nutrition Group (PENG) of the British Dietetic Association 15.10 Dietitians Business Meeting 15.35 Coffee 16.00 AGM and presentation of prizes. Handover of Presidency from Mary Phillips to Andrew Hart 16.30 Close